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The erectogenic potential of alkaloids extracted from Bitter leaf (Vernonia amyg‐
dalina) and Black nightshade (Solanum nigrum) was investigated in this study. Fresh 
leaves obtained from Bitter leaf and Black night shade were air‐dried, pulverized, and 
extracted for alkaloids. The inhibitory potential of the alkaloid extracts on arginase 
and phosphodiesterase‐5 (PDE‐5) activities in rats penile tissue was determined in 
vitro. The antioxidant properties were also evaluated and the constituent alkaloids 
quantified	using	GC‐MS.	The	alkaloid	extracts	inhibited	arginase	(0–30.51	μg/ml) and 
PDE‐5	 (0–133.69	μg/ml) activities in a concentration‐dependent pattern. Similarly, 
the alkaloid extracts inhibited Fe2+‐induced lipid peroxidation in rats penile tissues, 
scavenged	DPPH,	OH,	and	NO	radicals	as	a	function	of	concentration.	GC‐MS	char‐
acterization revealed over 20 alkaloid compounds. The inhibition of PDE‐5‐, argin‐
ase‐, pro‐oxidant‐induced lipid peroxidative‐, and free radicals‐scavenging activities 
by the alkaloids is suggestive of putative mechanisms underlying their therapeutic 
use for managing erectile dysfunction in folklore medicine.
Practical applications
Alkaloids	extracted	from	Black	nightshade	(Solanum nigrum) and Bitter leaf (Vernonia 
amygdalina) were characterized and investigated by standard procedures for inhibi‐
tory action against key erectile dysfunction‐linked enzymes and antioxidant activity. 
The alkaloids inhibited erectile dysfunction‐linked enzymes (arginase and PDE‐5) and 
showed considerable antioxidant activity in a concentration‐dependent manner. In 
view of this, we suggest the application of these results in the development of erec‐
tile dysfunction drugs in the pharmaceutical industry, with probable minimal or no 
adverse effect.
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1  | INTRODUC TION
Erectile dysfunction (ED) or male sexual impotence is a condition 
whereby men experience repeated inability to achieve or sustain 
firm	 penile	 erection	 for	 a	 gratifying	 sexual	 activity	 (Montorsi	 et	
al., 2010). Erectile capacity decreases as men age, some men ex‐
perience chronic, severe, or mild ED at some particular stages of 
their	lives,	usually	at	age	40	(Van‐Wyk,	2015).	Aside	of	age,	other	
causative factors have been reported in the literature. Impairment 
to and/or insufficient arterial blood flow within the hypogastric 
penile bed and into the corpora cavernosa, damages to penile 
endothelial tissue, perturbations in the nervous system mod‐
ulating erection or reduced libido are some of the causes of ED 
(Lue,	 2000).	 Also,	 oxidative	 stress‐related	 reactive	 oxygen	 and	
nitrogen species (ROS and RNS) are risk factors for ED. These 
species attack important cellular macromolecules, such as lipids 
and proteins, thereby resulting in endothelial tissue dysfunction 
(Nchegang	et	al.,	2016).	The	reactive	species	are	implicated	in	re‐
duction of the bioavailability of NO, which is critically required for 
penile	erection	 (Nchegang	et	al.,	2016).	Living	an	unhealthy	 life‐
style, obesity, smoking, alcoholism, abuse of drugs/medications, 
stress, fatigue, anxiety, fear, sadness, relationship problems, phys‐
ical/psychological disorders, and unbeneficial enzyme activities 
are additional factors responsible for the incidence of ED (Cleland 
& Cotton, 2011).
Arginase	which	 is	 implicated	 in	 ED	 is	 a	metal	 containing	 en‐
zyme that acts on L‐arginine and convert it into urea and ornithine 
while Nitric Oxide Synthase (NOS) converts the same L‐arginine to 
nitric oxide and citrulline during sexual stimulation, which brings 
about reduction in bioavailability of NO. Both enzymes compete 
for	 the	 substrate,	 L‐arginine	 (Boucher,	Moali,	&	Tenu,	 1999)	 and	
are also linked with ED (Oboh et al., 2015). Similarly, PDE‐5 is a 
vital	 enzyme	 in	 the	NO/cGMP	 signal	 transduction	 pathway	 that	
controls smooth muscle cells twitch and erectile system (Leite et 
al., 2007). Leite et al. (2007) stated further that PDE‐5 enzymes 




are reported to provoke some side effects and aftermath expe‐
riences	 (Kloner,	 Mitchell,	 &	 Emmick,	 2003;	 Shabsigh,	 Kaufman,	
Steidle, & Padma‐Nathan, 2004).
Recourse to therapeutic solutions from plant sources has always 
been an attractive option with little or no side effects for managing 
diseased conditions such as ED. Several plants are known to have 
diverse pharmacological and medicinal properties, most of which 
are edible and have no side effects (Gratz, Flurer, & Wolnik, 2004; 
Omojokun,	 Oboh,	 &	 Ademiluyi,	 2018).	 Bitter	 edible	 plants	 (e.g.,	
Vernonia amygdalina and Solanum nigrum) have the reputation of 
being aphrodisiacs (Kim, Woo, Lee, & Kim, 1998). The sexual activ‐
ity enhancing potential of these plants is ascribed to phytochemical 
constituents such as sterols, phenols, alkaloids, amino acids, and 
saponin	 (Eleazu,	 Eleazu,	 Awa,	 &	 Chukwuma,	 2012).	 These	 com‐
pounds are responsible for improving sexual function through the 
regulation of neurotransmitters and relaxation of the corpora cav‐
ernosa smooth muscles (Kumar, Subramoniam, & Pushpangadan, 
2000). It is noteworthy that the bitter‐tasting Solanum nigrum and 
Vernonia amygdalina are affirmed to have considerable therapeu‐
tic effects, which are attributed to their alkaloid contents (Jamil, 
Shahid,	Khan,	&	Ashraf,	 2007;	Manoko,	van	den	Berg,	 Feron,	van	
der	 Weerden,	 &	 Mariai,	 2007).	 Other	 phytoconstituents	 report‐
edly present in the vegetables include sesquiterpenes, flavonoids, 
phenolic acids, and alkaloids among others (Eleazu et al., 2012). 
Alkaloids	are	one	of	the	readily	available	antioxidants	found	in	bitter	
plants	(Nchegang	et	al.,	2016).	In	view	of	the	foregoing,	this	study	
sought to provide information on possible erectogenic potential 
of alkaloids extracted from Black nightshade (Solanum nigrum) and 
Bitter leaf (Vernonia amygdalina) as alternative therapeutic agents 
for managing erectile dysfunction.
2  | MATERIAL S AND METHODS
2.1 | Sample collection
Leaves of Black nightshade and Bitter leaf were harvested from a 
vegetable garden at Elizade University, Ilara‐mokin with General 
Packet	Radio	Service	(GPRS)	of	7.3497°	N,	5.1067°	E,	Ondo	State,	





Except where otherwise stated, all reagents and chemicals used are 
of analytical grade. Distilled water used was obtained from the labo‐
ratory water distiller.
2.3 | Extraction of plant alkaloids
Leaves collected from the two plant samples were separately ex‐
tracted for alkaloids by following the same procedure described 
by	Ademiluyi,	Ogunsuyi,	and	Oboh	(2016).	The	leaves	were	thor‐
oughly rinsed under running tap, air‐dried at temperature between 
25 and 27°C and pulverized to powder form. Powdered samples 
were defatted for 24 hr using N‐hexane and subsequently soaked 
in 10% acetic acid in ethanol for 24 hr at 37°C. The mixtures of the 
different samples were first filtered with muslin cloth and subse‐
quently through Whatman No.2 filter paper. Filtrates were later 
concentrated at 45°C in a rotary evaporator and precipitated with 
concentrated ammonium hydroxide (NH4OH). The precipitates 
were then collected and washed with more diluted ammonium hy‐
droxide (NH4OH) so as to obtain the crude alkaloid extracts of the 
two plant materials.
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2.4 | Preparation of penile tissue homogenate
All	 animals	 used	 were	 Wistar	 albino	 rats	 strain	 obtained	 from	
University	 of	 Ibadan	 Animal	 House,	 Ibadan,	 Oyo	 state.	 The	 ani‐
mals	were	kept	in	battery	cages	at	room	temperature	(21–25°C),	all	
other appropriate conditions for animal experiments were carefully 
observed.	All	 rats	were	 given	 access	 to	water	 and	 animal	 feed	 ad	
libitum. The international guidelines as well as the stipulated guide‐
lines	 of	 Elizade	 University	 Faculty	 of	 Basic	 and	 Applied	 Sciences	
Animal	and	Research	Ethics	Committee	(in	line	with	European	Union	
Directive	2010/63/EU)	were	followed	for	all	animals	used.
For the lipid peroxidation assays, five adult male Wistar rats 
strain weighing between 240 and 280 g were sacrificed by cervi‐
cal dislocation after which the penile tissues were quickly isolated, 
weighed,	and	temporarily	stored	at	approximately	−4°C,	and	subse‐
quently homogenized in cold saline. Isolated tissue was centrifuged 
for about 10 min at 3,000 × g to yield the supernatant and then 
the pellet. The pellet was discarded while the supernatant was put 






Three male Wistar albino rats weighing between 200 and 250 g 
were sacrificed by cervical dislocation. The penile tissues were care‐
fully	removed	and	washed	twice	in	0.1	M	Tris‐HCl	buffer	containing	
1	mM	of	CaCl2	and	50	mM	of	NaCl	(pH	8.0)	and	stored	in	firm	glass‐
ware and placed on ice crystals. The tissues were then homogenized 
and centrifuged at 15,000 g, 4°C for 15 min. The supernatant was 
decanted and used as enzyme source. The PDE‐5 inhibitory activ‐
ity of the alkaloid extracts was assayed in vitro by the method of 
Kelly	and	Butler	(1977)	with	slight	modification	by	Oboh,	Adebayo,	
Ademosun,	 and	 Boligon	 (2017).	 The	 reaction	 mixture	 containing	
5	mM	of	the	substrate	(p‐nitrophenyl	phenylephosphate),	100	µl	of	
enzyme,	20	mM	of	Tris	buffer	(pH	8.0),	and	the	extracts,	was	incu‐
bated at 37°C for 10 min. The intensity of p‐nitrophenol produced 
was measured as change in absorbance after 5 min at 400 nm using 
a	UV	Visible	spectrophotometer	(Jenway	6315	model).	The	control	
experiment was performed without the test sample, and the effec‐
tive alkaloid extract concentration eliciting PDE‐5 inhibitory activity 
was expressed as percentage inhibition.
2.5.2 | Arginase inhibition
Four male Wistar albino rats strain weighing between 240 and 
280 g were sacrificed by cervical dislocation. The penile tissues 
were	 carefully	 removed,	 washed	 in	 0.01	 M	 of	 Tris‐HCl	 buffer	
containing	0.05	M	of	MnCl2 (pH 9.5) and stored in firm glassware 
placed on ice crystals. The tissues were later homogenized in three 
volumes of ice‐cold buffer. The homogenate was centrifuged at 
15,000 g, 4°C for 15 min. The supernatant was decanted and 
used	as	enzyme	source.	Arginase	activity	was	determined	by	the	
measurement of urea produced by reaction with Ehrlich's reagent. 
The	reaction	mixture	comprised	in	final	concentration	of	1.0	mM	
of	 Tris‐HCl	 buffer	 (pH	 9.5)	 containing	 1.0	 mM	 of	MnCl2,	 0.1	M	
of	 arginine	 solution,	 and	50	mM	of	 the	enzyme	preparation	 in	a	
final volume of 1.0 ml. The mixture was incubated for 10 min at 
37°C. Reaction was terminated by adding 2.5 ml of Ehrlich reagent 
which contain 2.0 g of p‐dimethylaminobenzaldehyde in 20 ml of 
concentrated hydrochloric acid and made up to 100 ml with dis‐
tilled water. The optical density reading was taken after 20 min 
at	 450	 nm	using	 a	UV	Visible	 spectrophotometer	 (Jenway	 6315	
model). The control experiment was performed without the test 
sample, and the arginase inhibitory activity expressed as % inhibi‐
tion (Kaysen & Strecker, 1973).
2.5.3 | Lipid peroxidation
The method of Ohkawa, Ohishi, and Yagi (1979) which was slightly 
modified was used for the lipid peroxidation and thiobarbituric acid 
reactions. Hundred microliter of homogenate supernatant (Sl frac‐
tion)	was	mixed	with	30	µl	 of	Tris‐HCl	buffer,	 extracts	 (0–100	µl)	
and	30	µl	of	FeSO4 or sodium nitroprusside (as pro‐oxidant). Volume 
was	made	up	to	300	µl	with	water	and	incubated	at	37°C	for	60	min.	





2.5.4 | 1,1‐diphenyl‐2‐picrylhydrazyl (DPPH) free 
radical scavenging ability
Gyamfi,	 Yonamine,	 and	 Aniya	 (1999)	 method	 was	 used	 for	 the	
DPPH (1,1‐diphenyl‐2 picrylhdrazyl) radical scavenging activ‐
ity.	An	appropriate	dilution	of	the	extracts	in	the	ratio	1:1	(10	ml	
of extract solution plus 10 ml of distilled water) was mixed with 
1,000 μl	of	0.4	mM	methanol	containing	DPPH	radicals,	mixture	
was incubated in dark cupboard for 30 min and absorbance was 
measured	at	516	nm.
2.5.5 | Inhibition of Fenton reaction (degradation of 
deoxyribose)
Halliwell, Gutteridge, and Cross (1992) method was used to de‐
termine	 the	 extracts'	OH	 radical	 scavenging	 ability.	 50–200	µl	 of	
the extract was added to a reaction medium containing deoxy‐
ribose, phosphate buffer, FeSO4,	 and	 distilled	water.	Mixture	was	
incubated for 30 min at 37°C and the reaction was then halted by 
adding	 trichloroacetic	 acid	 (TCA).	 Subsequently,	TBA	solution	was	
added and tubes were then incubated for 20 min in water at 100°C. 
Absorbance	was	measured	using	a	spectrophotometer	at	532	nm.
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2.5.6 | Nitric oxide (NO) radical scavenging
Marcocci,	Maguire,	Droylefaix,	and	Packer	(1994)	method	was	used	
to assay for the NO radical scavenging potential of the alkaloid 
extracts.	100–400	μl of alkaloid extract was added to 1,000 μl of 
Sodium nitroprusside solution and incubated for 120 min at 37°C. 
Five hundred microliter of the incubation mixture was extracted 
and then mixed with 300 μl of Griess reagent (containing sulfa‐
nilamide in H3PO4 and napththlyethylenediamine dihydrochloride). 
Chromophore absorbance was instantly read at 570 nm against dis‐
tilled water as blank.
2.5.7 | GC‐MS quantification of alkaloid 
constituents
The	aliquot	used	for	the	GC‐MS	qualitative	characterization	analysis	





inert mass spectrometer (with triple axis detector) and electron im‐
pact	 source	 (Agilent	 Technologies).	 The	 stationary	 phase	 of	 sepa‐




initial nominal pressure of 2.84 psi and at an average velocity of 
46	 cm/s.	 One	microliter	 of	 the	 samples	 were	 injected	 in	 splitless	
mode	at	an	injection	temperature	of	260°C.	Purge	flow	was	21.5	ml/
min at 0.50 min with a total gas flow rate of 25.8 ml/min; gas saver 
mode	was	switched	on.	The	oven	was	initially	programmed	at	60°C	
(1 min), then ramped at 4°C/min to 110°C (3 min), followed by tem‐
perature	programme	rates	of	8°C/min	to	260°C	(5	min)	and	10°C/
min	 to	300°C	 (12	min).	Run	 time	was	56.25	min	with	a	3	min	sol‐
vent delay. The mass spectrometer was operated in electron‐impact 
ionization mode at 70eV with ion source temperature of 230°C, 
quadrupole temperature of 150°C and transfer line temperature of 
280°C. Scanning of possible alkaloid compounds was from m/z 30 
to	550	amu	at	2.62s/scan	scan	rate	and	were	identified	by	compar‐
ing measured mass spectral data with those in NIST 14 Mass Spectral 
Library and literature.
Prior	 to	 analysis,	 the	 MS	 was	 auto‐tuned	 to	 perfluorotribu‐
tylamine	 (PFTBA)	 using	 already	 established	 criteria	 to	 check	 the	
abundance of m/z	 69,	219,	502	and	other	mechanism	optimal	 and	
sensitivity conditions.
Analysis	validation	was	conducted	by	running	replicate	samples	
in order to see the consistency of the constituent compound name, 
respective retention time, molecular weight (amu), Quality ion (Q‐
Ion), and % Total.
Each compound identified via the NIST 14 Library Search report 




The mean ± standard deviation (SD) was estimated after pooling 
out results of replicate experiments as described by Zar, 1984. EC50 
which is the concentration of alkaloid extract causing 50% antioxi‐
dant activity or enzyme inhibition was calculated using nonlinear 
regression analysis.
3  | RESULTS
PDE‐5 inhibitory potential of the alkaloid extracts from Bitter leaf 
and	Black	nightshade	in	rats'	penile	tissue	in	vitro	was	assessed.	As	
presented in Figure 1, the result showed that both extracts inhib‐
ited PDE‐5 in a concentration‐dependent pattern. It is noteworthy 
that the alkaloid extract from Bitter leaf (107.99 μg/ml) significantly 
(p > 0.05) exhibited higher PDE‐5 inhibitory potential than Black 
nightshade	 (133.69	 μg/ml) as indicated in Table 1. Furthermore, 
the ability of the alkaloid extracts from Bitter leaf and Black night‐
shade to inhibit arginase activities in rats' penile tissues in vitro is 
presented	 in	Figure	2	with	Black	nightshade	 (26.92	μg/ml) signifi‐
cantly (p > 0.05) showing higher inhibitory activity than Bitter leaf 
(30.51 μg/ml).
Assaulting	rats	penile	 tissue	homogenate	with	250	µM	of	Fe2+ 
significantly increased (p	<	0.05)	 the	malondialdehyde	 (MDA)	con‐
tent (Figure 3). However, incubation of the challenged penile tissue 
homogenate with the crude alkaloid extracts showed inhibition 
of	 MDA	 produced	 in	 concentration‐dependent	 (0–210.08	 µg/ml)	
manner (Table 1). In contrast, the alkaloid extract from Bitter leaf 




Abundance of individual constituents
Total abundance of all constituents in extract
×100
F I G U R E  1   Phosphodiesterase‐5 Inhibitory activity of crude 
alkaloid extracts from Bitter leaf and Black nightshade in rat penile 
tissue
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Figure 4 presents the DPPH radical scavenging ability of the 
crude alkaloid extracts from Bitter leaf (Vernonia amygdalina) and 
Black nightshade (Solanum nigrum). The result revealed that they 
both scavenged DPPH radicals in a concentration‐dependent pat‐
tern. However, as shown by the EC50 values in Table 1, Bitter leaf 
(55.77	µg/ml)	significantly	exhibited	higher	scavenging	ability	than	
Black	 nightshade	 (62.38	 µg/ml).	 The	 hydroxyl	 radical	 (OH)	 scav‐
enging ability of Bitter leaf and Black nightshade as presented in 
Figure 5 showed that the alkaloid extracts scavenged OH as typified 
by the induced breakdown of deoxyribose in concentration‐depen‐
dent	pattern.	As	 indicated	 in	Table	1,	 EC50 values show no signif‐
icant difference in the OH radical scavenging ability of Bitter leaf 
(242.72	µg/ml)	 and	Black	 nightshade	 (241.55	µg/ml).	 The	 alkaloid	
extracts of Bitter leaf and Black nightshade scavenged NO radical in 
a	concentration‐dependent	pattern	(Figure	6)	with	Black	nightshade	
(625.09	µg/ml)	significantly	(p > 0.05) exhibiting higher NO radical 
scavenging	ability	than	Bitter	leaf	(735.29	µg/ml).	The	GC‐MS	char‐
acterization and chromatogram of constituent alkaloid compounds in 
Bitter leaf are shown in Table 2 and Figure 7, respectively. Similarly, 
Figure 8 shows the chromatogram of the alkaloid compounds in 
Black nightshade with the constituent alkaloids detailed in Table 3.
4  | DISCUSSION
Plant‐derived foods and herbs with medicinal properties have been 
used in folklore medicines of many nations of the world from time 
immemorial to manage and treat various health challenges such as, 
hypertension, diabetes mellitus, cancer, erectile dysfunction, and 
others (Oboh & Rocha, 2007). V. amygdalina and S. nigrum have tra‐
ditionally been used as pain relieving, antispasmodic, germ‐free, 
antinarcotic, diuretic, balmy, purgative, anticancer agents, and for 
the	 management	 of	 neuronal	 disorders	 (Ayesha,	 Zaheer‐Ud‐Din,	
Mushtaq,	&	Muhammad,	2010;	Manoko	et	al.,	2007).	The	therapeu‐
tic attributes have been predicated on the occurrence of abundant 
base phytonutrients such as phenols, alkaloids, glycosides, and fla‐
vonoid. These phytonutrients have considerable antioxidative prop‐
erties (Oboh et al., 2015; Omojokun et al., 2018). The antioxidant 
properties and ED‐ameliorating potential of alkaloids extracts from 
V. amygdalina and S. nigrum were investigated in this study using 
standard protocols.
Penile erection is dependent on smooth muscle relaxation in 
the corpus cavernosum. The key mediator of the relaxation pro‐
cess	is	NO,	which	acts	by	increasing	the	cellular	level	of	cGMP,	the	
key	 second	 messenger	 mediating	 penile	 erection	 (Lugnier,	 2006).	
An	increase	in	cGMP	levels	can	be	induced	by	inhibition	of	PDE‐5,	
TA B L E  1   EC50 values of radical scavenging and enzymes 
inhibitory ability of crude alkaloid extracts from Bitter leaf 
(Vernonia amygdalina) and Black nightshade (Solanum nigrum)
 
EC50 of radical scavenging and enzyme 
inhibitory ability (µg/ml)
Bitter leaf Black nightshade
DPPH 55.77 ± 1.35a 62.38	±	2.48b
OH 242.72 ± 3.3a 241.55 ± 5.4a
NO 735.29 ± 4.5b 625.09	±	2.8a
Fe2+‐induced lipid 
peroxidation
165.01	±	2.7a 210.08 ± 5.5b
Phosphodiesterase‐5 
Inhibitory activity
107.99 ± 4.2a 133.69	±	2.8b
Arginase	Inhibitory	
activity
30.51 ± 1.2b 26.92	±	1.1a
Note: Values represent mean ± standard deviation (n = 3). Values with 
the same superscript number on the same row are not significantly 
(p < 0.05) different.
F I G U R E  2  Arginase	Inhibitory	activity	of	crude	alkaloid	extracts	from	Bitter	leaf	and	Black	nightshade	in	rat	penile	tissue
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the	 predominant	 isoenzyme	 metabolizing	 cGMP	 in	 the	 cells	 of	
the corpus cavernosum. PDE‐5 is a pharmacologic target in erec‐
tile	dysfunction	(Corbin,	Francis,	&	Webb,	2002).	Any	 inhibitors	of	
PDE‐5 activity is a potential candidate for managing or treating ED. 
Previous studies have recognized plant alkaloids as PDE‐5 inhibitors 






that reduces intracellular calcium level, upgrades muscle relaxation, 
and thus triggers penile erection (Lue, 2000). The PDE‐5 inhibitory 
activity observed in V. amygdalina and S. nigrum varied directly with 
the	concentration	of	alkaloids	up	to	a	maximum	of	(108	µg/ml)	and	
(133	µg/ml)	for	both	plants,	respectively.	V. amygdalina showed sig‐
nificantly (p > 0.05) higher inhibitory activity than S. nigrum. These 
results are noteworthy and justify their continuous use in the man‐
agement of ED in trado‐medical practices. This corroborates a recent 
report that Hunteria umbellata and Anogeissus leiocarpus inhibited 
PDE‐5 activity in rats' penis (Oboh et al., 2017). These finding is also 
in agreement with previous reports which described the mecha‐
nism of action of therapeutics used in the management of erectile 
dysfunction (Bivalacqua, Champion, Hellstrom, & Kadowitz, 2000; 
F I G U R E  3   Inhibition of Fe2+‐induced lipid peroxidation in rat penile tissue by crude alkaloid extracts from Bitter leaf and Black 
nightshade
F I G U R E  4   DPPH radical scavenging ability of alkaloid extracts from Bitter leaf and Black nightshade leaves
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Hatzichristou & Pescatori, 2001). We therefore suggest that these 
plants are viable sources of remedies or potent anti‐PDE‐5 factors 
from which valuable ED‐effective drugs with minimal or no adverse 
effects can be developed. Inhibition of PDE‐5 by these plants is ex‐
pected	to	enhance	penile	erection	by	preventing	cGMP	degradation.	
This possibility should give an advantage over branded drugs, such 
as sildenafil, which is a selective inhibitor of PDE‐5 and an effective 
drug for ED treatment, but with reported side effects in retinal, vas‐
cular, and visceral tissues (Corbin et al., 2002).
The inhibition of arginase activity is adjudged to play a key 
function in the biochemistry of ED (Toque et al., 2011). Bivalacqua, 
Burnett, Hellstrom, and Champion (2007) and Goswami, Inamdar, 
Jamwal, and Dethe (2014) recommended that food sources with ar‐
ginase inhibition potentials are useful for the management of ED.
The inhibition of arginase in penile NOS movement, re‐estab‐
lishes endothelial‐determined NO vasodilatation, and erectile ca‐
pacity. Importantly, the arginase inhibitory potential displayed by 
the alkaloid extracts from the edible vegetables used in this study 
could render it a unique nutraceutical in ameliorating ED since it 
could expand the availability of NO in the body system (Berkowitz 
et al., 2003; Durante, Johnson, & Johnson, 2007) through arginase 
inhibition. Polyphenols are reportedly affirmed to aid the gener‐
ation of hydrogen bond and its interactions at the arginase active 
site	 and	 thus	 inhibit	 the	 enzyme's	 activity	 (Dos‐Reis,	Manjolin,	 do	
CarmoMaquiaveli,	 Santos‐Filho,	&	da	Silva,	2013).	Hence,	we	 sug‐
gest alkaloid extracts from Black nightshade and Bitter leaf could be 
used for the management of ED having observed a strong inhibition 
of arginase activity in this study.
F I G U R E  5   OH* scavenging ability of alkaloid extracts from Bitter leaf and Black nightshade leaves
F I G U R E  6   NO radical scavenging ability of crude alkaloid extracts from Bitter leaf and Black nightshade
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The result gathered from this study revealed that crude alkaloid 
obtained from the two edible bitter vegetables exhibited DPPH, nitric 
oxide (NO), and hydroxyl (OH) radicals scavenging properties. In living 
system, hydroxyl radical (OH) are produced from hydrogen peroxide 
and/or	 superoxide	 anion	 (Tushar,	 Mas,	 &	 Kaneez,	 2015).	 Hydroxyl	
radical is believed to play a significant function in ED (Gazzaruso et 
al., 2008) and it is known to be profoundly receptive, vivacious, short 
lived, and very dangerous to living cells (Sikka & Hellstrom, 2002). In 
addition, nitric oxide radical is implicated in numerous processes toxic 
to the cells and neurons which could in turn contribute to plaque for‐
mation in penile tissue. This radical which is majorly generated as a 
result of distress or inflammation (Kang et al., 2003) may thus lead to 
endothelial dysfunction. In the same vein, NO which plays vital func‐
tion in the commencement of penile erection could as well consolidate 
F I G U R E  7   Bitter leaf (Vernonia amygdalina)	GC‐MS	chromatogram
F I G U R E  8   Black nightshade (Solanun nigrum)	GC‐MS	chromatogram
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TA B L E  2   Constituent alkaloid compounds in Bitter leaf (Vernonia amygdalina)
SN
Retention time 
(min) Compound name/hit name
Quality ion (relative 
intensity, %)
% Total of all compound 





1 3.306 Oxirane, (propoxymethyl)‐ 50 0.2520 003126‐95‐2 8273
2 3.425 Hydroxyacetic acid, hydrazide 50 1.9770 003530‐14‐1 2253
3 3.847 Carbohydrazide 9 0.1610 000497‐18‐7 2399
4 4.066 Methanimidamide,	N,N‐ 
dimethyl‐N′‐(3‐nitrophenyl)‐
35 0.3870 002103‐47‐1 58907
5 4.149 Acetic	acid	hydrazide 38 0.1620 001068‐57‐1 788
6 4.298 2‐Amino‐8‐[3‐d‐ribofuranosyl]
imidazo[1,2‐a]‐s‐triazin‐4‐one
17 0.2510 067410‐65‐5 142414
7 5.034 1‐Hexanamine 22 0.5240 000111‐26‐2 4205
8 5.200 1,3‐Bis(2‐chloroethyl)urea 9 0.2130 002214‐72‐4 51564
9 5.989 p‐Dioxane, methylene‐ 9 0.2050 003984‐19‐8 3741
10 6.126 MDMA	methylene	homolog 4 0.2890 1000386‐32‐2 71431
11 6.327 Dimethylamine 9 2.0550 000124‐40‐3 88
12 6.844 Alpha	methyl	3,6‐anhydro,	
D‐Mannopyranoside	
9 0.0950 015814‐56‐9 44787
13 10.880 5,6‐Dihydro‐2‐(4‐nitrophenyl)‐
4H‐1,3‐oxazin‐5‐one
4 0.1220 077580‐72‐4 82808
14 19.023 Propanamide, N,N‐dimethyl‐ 5 0.1210 000758‐96‐3 4168
15 19.759 Furan, 2,5‐dihydro‐3‐methyl‐ 7 0.1110 001708‐31‐2 1460
16 19.884 Pyrrolidine, 3‐methyl‐ 4 0.1910 034375‐89‐8 1596
17 21.540 Acetamide,	2‐fluoro‐ 4 0.2150 000640‐19‐7 987
18 22.228 N‐Methylallylamine 46 0.6270 000627‐37‐2 618
19 24.276 Borane carbonyl 4 0.1580 013205‐44‐2 65
20 25.012 Aminopyrazine 5 0.1920 005049‐61‐6 2676
21 25.326 Oxalic acid, isobutyl pentyl 
ester
33 0.1030 1000309‐37‐0 79373
22 25.445 Azetidine,	1‐methyl‐ 5 0.0970 004923‐79‐9 622
23 25.872 Neophytadiene 93 5.6850 000504‐96‐1 138502
24 26.442 3,7,11,15‐Tetramethyl‐2‐ 
hexadecen‐1‐ol
58 1.7950 102608‐53‐7 155865
25 26.686 1‐Fluorononane 12 0.3200 000463‐18‐3 22849
26 26.846 3(2H)‐Thiophenone, dihydro‐, 
oxime, 1,1‐dioxide
4 0.0940 1000327‐57‐0 24070
27 27.297 Azetidine,	1‐methyl‐ 5 0.1240 004923‐79‐9 622
28 29.903 1,3‐Cyclooctadiene 76 1.4180 001700‐10‐3 5507
29 30.039 Hexadecanamide 93 1.6450 000629‐54‐9 116301
30 30.205 Ethyl hydroden pimelate 47 0.6010 1000342‐35‐7 54902
31 31.452 5‐(Prop‐2‐enoyloxy)
pentadecane
25 0.2610 1000245‐67‐6 142102
32 31.624 5‐Butyl‐1,3‐oxathiolan‐2‐one 32 0.2920 1000254‐54‐5 32188
33 31.962 9‐Octadecenamide, (Z)‐ 55 3.7050 000301‐02‐0 141030
34 33.072 Cyclohexanooxazin‐2(1H)‐one, 
3,9‐dihydro‐6,8‐isopro‐
pylideno‐9‐methyl‐
9 0.1010 1000260‐31‐8 71560
(Continues)
10 of 16  |     OMOJOKUN et al.
SN
Retention time 
(min) Compound name/hit name
Quality ion (relative 
intensity, %)
% Total of all compound 





35 33.309 Carbamic acid, ethylnitroso‐, 
ethyl ester
9 0.2740 000614‐95‐9 22338
36 33.636 2‐Trifluoroacetoxytridecane 10 0.2550 116465‐18‐0 155165
37 33.802 1,2‐Benzisothiazole, 3‐methyl‐ 9 0.2660 006187‐89‐9 24231
38 33.998 Propanal,3‐hexylimino‐2‐nitro‐ 9 0.3130 339192‐83‐5 65617
39 35.185 1‐(2‐Adamantylidene)
semicarbazide
9 0.3830 065814‐27‐9 71395
40 35.363 2‐Carbamyl‐9‐[.beta.‐d‐ribo‐
furanosyl]hypoxanthine
17 0.1760 121358‐21‐2 154058
41 35.743 1,3,5‐Triazine, 
2‐chloro‐4,6‐bis(methylthio)‐
9 0.8770 004407‐40‐3 71684
42 36.141 Formamide, N,N‐dimethyl‐ 9 0.4140 000068‐12‐2 751
43 36.485 Squalene 90 1.5360 000111‐02‐4 243220
44 36.948 Carbamic acid, (cyanoacetyl)‐, 
ethyl ester
9 0.0990 006629‐04‐5 29595




9 0.1600 017939‐34‐3 141077
47 39.577 2‐quinoxalinamine, 
3‐chloro‐N‐ethyl‐
5 0.2090 1000400‐56‐1 71161
48 40.479 (9‐Oxo‐9,10‐dihydroacridin‐4‐
yl)acetic acid
5 0.1320 145447‐90‐1 114253
49 40.628 5H‐dibenzo[a,d]
cyclohepten‐5‐amine
5 0.1290 1000400‐55‐2 71669
50 40.734 N‐Isopropyl‐3‐ 
phenylpropanamide
9 0.0870 056146‐87‐3 56865
51 41.340 Benzenemethanamine, 4‐
methoxy‐N,N‐dimethyl‐.
alpha.‐(dimethylamino)‐
9 0.7630 122687‐84‐7 72391
52 42.076 Purine‐2,6‐dione,	8‐(3‐ 
ethoxypropylamino)‐1,3‐ 
dimethyl‐3,9‐dihydro‐




22 0.1980 1000305‐50‐9 140840
54 42.331 Propanamide, 3‐bromo‐N‐(4‐
bromo‐2‐chlorophenyl)‐




35 2.3990 1000111‐66‐9 157264
56 44.165 3‐Quinolinecarboxylic acid, 
6,8‐difluoro‐4‐hydroxy‐,	 
ethyl ester
35 0.4380 1000362‐34‐6 114062
57 44.284 N‐Methyl‐1‐ 
adamantaneacetamide




38 0.2650 1000409‐38‐7 197998
TA B L E  2   (Continued)
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with superoxide to produce another free radical and toxic compound 
known as peroxynitrite. This can promote the development of lipid 
peroxidation and prompt the arrangement of malondialdehyde and hy‐
droxides	which	are	factors	in	ED	pathophysiology	(Agarwal,	Nandipati,	
Sharma,	 Zippe,	 &	 Raina,	 2006).	Thus,	 as	 a	 result	 of	 the	 endothelial	
dysfunction caused by NO, reducing its bioavailability will be a good 
approach	 to	 ED	 treatment	 (Akomolafe,	 Oboh,	 Oyeleye,	 &	 Boligon,	
2016).	Also,	inhibition	of	lipid	peroxidation	induced	by	Fe2+ in rats' pe‐
nile tissue homogenate by the vegetables crude alkaloid extracts is an 
expression of strong antioxidant magnitude. Bio‐membrane and bio‐
molecules peroxidation is reported to be associated with the advance‐
ment	of	various	health	challenges.	Also,	iron	is	reported	to	be	involved	
in inducing lipid peroxidation in living system as its disruption could 
lead to iron overload which is implicated in oxidative stress‐induced 
ED	(Agarwal	et	al.,	2006).	Therefore,	OH	and	Fe2+ radical scavenging 
ability is acknowledged efficient antioxidant mechanisms. Hence, the 
abilities of the alkaloid extracts to scavenge these free radicals as 
shown in this study could be valuable in erectile dysfunction manage‐
ment	(Maggi,	Filippi,	Ledda,	Magini,	&	Forti,	2000).
Medicinal	values	of	herbs	and	vegetables	are	mainly	attributed	
to their phytoconstituents, for example, flavonoids, hydroxy‐
cinnamic acids (Omojokun et al., 2018) terpenes, and alkaloids. 
Various researchers have reported auspicious health boosting 
potentials (Dinchev et al., 2008; Jamil et al., 2007) of alkaloids. 
The inhibitory potential of alkaloid extracts from Black nightshade 
and Bitter leaf on the activities of enzymes linked with erectile 
dysfunction as well as their antioxidative properties exhibited 
could be attributed to the synergistic activity of many alkaloid 




(min) Compound name/hit name
Quality ion (relative 
intensity, %)
% Total of all compound 





59 44.865 acetic acid, 2‐[bis(methylthio)
methylene]‐1‐phenylhydrazide
43 0.4870 1000401‐44‐4 114619
60 45.720 2,4‐Cyclohexadien‐1‐one, 
3,5‐bis(1,1‐dimethylethyl)‐4‐
hydroxy‐
41 1.2720 054965‐43‐4 85540
61 46.860 2′‐Hydroxypropiophenone,	
TMS	derivative
46 0.9960 033342‐87‐9 85144
62 47.061 2‐Methyl‐7‐phenylindole 38 0.2440 001140‐08‐5 71646
63 47.631 2‐Ethylacridine 46 6.1830 055751‐83‐2 71643
64 48.878 Cyclotrisiloxane, hexamethyl‐ 43 1.6110 000541‐05‐9 85992
65 49.804 Trimethylsilyl 3‐methyl‐4‐[(tri‐
methylsilyl)oxy]benzoate
38 0.3150 1000378‐73‐2 155034
66 49.904 Benzo[h]quinoline,	
2,4‐dimethyl‐
43 1.9650 000605‐67‐4 71668
67 50.029 1,1,1,3,5,5,5‐
Heptamethyltrisiloxane
38 0.8640 001873‐88‐7 86044
68 50.468 Silicic acid, diethyl 
bis(trimethylsilyl) ester
59 2.8060 003555‐45‐1 154747
69 51.317 1,4‐Bis(trimethylsilyl)benzene 43 1.1740 013183‐70‐5 85161
70 52.047 Tris(tert‐butyldimethylsilyloxy)
arsane
43 0.6450 1000366‐57‐5 260810
71 53.151 1H‐Indole, 1‐methyl‐2‐phenyl‐ 43 0.5050 003558‐24‐5 71659
72 53.383 Arsenous	acid,	
tris(trimethylsilyl) ester
43 0.2580 055429‐29‐3 199618
73 55.033 1,2‐Bis(trimethylsilyl)benzene 43 0.7560 017151‐09‐6 85160
74 55.602 Indole‐2‐one, 2,3‐dihydro‐N‐
hydroxy‐4‐methoxy‐3,3‐di‐
methyl‐
46 2.3050 1000129‐52‐1 71369
TA B L E  2   (Continued)
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TA B L E  3   Constituent alkaloid compounds in Black nightshade (Solanum nigrum)
SN
Retention 
time (min) Compound name/hit name
Quality ion (rela‐
tive intensity, %)
Percentage total of all com‐
pound (% total) CAS number












9 0.131 1000224‐58‐6 271216
4 6.084 benzonitrile, 2‐[(1‐methyl‐
2(1H)‐pyridinylidene)
methyl]‐5‐nitro‐
9 0.242 1000396‐68‐1 114173
5 6.998 Carbamic acid, (cyanoacetyl)‐, 
ethyl ester
28 1.116 006629‐04‐5 29595
6 11.218 Sarcocapnidine 7 0.300 087069‐33‐8 185196
7 11.515 Quinazolin‐4(3H)‐one, 
2,3‐dimethyl‐




2 0.100 1000404‐26‐8 145424
9 19.035 Propanamide, N‐ethyl‐ 5 0.168 005129‐72‐6 4146
10 19.367 Propanamide, 
3‐phenyl‐N‐ethyl‐
25 0.448 1000407‐14‐7 45319
11 20.917 2H‐Azepin‐2‐one,	
hexahydro‐1‐methyl‐
5 0.106 002556‐73‐2 12116
12 22.875 4‐Pyridinecarboxylic acid, 
N′‐[[(1‐methylethyl)amino]
carbonyl]hydrazide
9 0.310 1000327‐64‐4 84758
13 24.780 Oxazole, trimethyl‐ 7 0.292 020662‐84‐4 6219
14 25.677 Acetamide,	2‐amino‐ 3 0.120 000598‐41‐4 784





10 0.160 108533‐24‐0 184055
17 30.039 Dodecanamide 64 1.267 001120‐16‐7 64236
18 30.478 Neophytadiene 53 0.519 000504‐96‐1 138502
19 30.811 MDMA	methylene	homolog 4 0.137 1000386‐32‐2 71431




25 0.170 077489‐44‐2 54780
22 31.962 8‐Methyl‐6‐nonenamide 50 2.508 1000293‐20‐9 39039
23 32.502 1‐(2‐Adamantylidene)
semicarbazide
4 0.166 065814‐27‐9 71395
24 32.775 2‐(1‐Piperidino)‐5‐nitropyri‐
dine
5 0.129 026820‐61‐1 71172
25 33.102 Dodecahydropyrido[1,2‐b]
isoquinolin‐6‐one
5 0.202 108873‐36‐5 71593
26 33.304 Acetamide,	2‐cyano‐ 4 0.446 000107‐91‐5 1352
(Continues)
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SN
Retention 
time (min) Compound name/hit name
Quality ion (rela‐
tive intensity, %)
Percentage total of all com‐
pound (% total) CAS number
Entry number in 
NIST14 library
27 34.390 Formamide, N,N‐dimethyl‐ 9 0.099 000068‐12‐2 751
28 34.758 o‐Veratramide 9 0.097 001521‐39‐7 49053
29 35.221 5‐Aminoisoxazole 9 0.164 014678‐05‐8 1351
30 35.523 4‐Allyl‐5‐furan‐2‐yl‐2,4‐dihy‐
dro‐[1,2,4]triazole‐3‐thione
5 0.226 1000300‐01‐3 71831
31 35.618 7‐Chloro‐4‐methoxy‐3‐meth‐
ylquinoline
5 0.094 1000213‐52‐2 71274
32 35.779 Benzenemethanamine, 4‐
methoxy‐N,N‐dimethyl‐.
alpha.‐(dimethylamino)‐
9 0.153 122687‐84‐7 72391
33 36.046 2‐p‐Nitrophenyl‐oxadia‐
zol‐1,3,4‐one‐5
5 0.224 1000147‐64‐6 71757
34 36.336 2‐Pyridinemethanol 3,5‐di‐
chloro‐4‐hydroxy‐6‐methyl‐












5 0.610 1000351‐59‐9 71830
38 37.642 2‐quinoxalinamine, 
3‐chloro‐N‐ethyl‐
9 0.142 1000400‐56‐1 71161
39 37.797 5H‐dibenzo[a,d]
cyclohepten‐5‐amine
5 0.228 1000400‐55‐2 71669
40 38.058 Hexahydropyridine, 
1‐methyl‐4‐[4,5‐dihy‐
droxyphenyl]‐
9 0.374 094427‐47‐1 71537
41 39.001 9‐Borabicyclo[3.3.1]nonane,	
9‐[3‐(dimethylamino)propyl]‐
5 0.216 1000160‐35‐2 71620
42 39.197 1,3,5‐Triazine, 
2‐chloro‐4,6‐bis(methylthio)‐





5 0.289 013450‐70‐9 140962
44 40.200 4‐Sulfamoyl‐thiophene‐2‐car‐
boxylic acid
5 0.148 1000300‐36‐6 71683
45 40.919 s‐Triazolo[4,3‐a]pyridine‐3‐
thiol, 5‐methyl‐
5 0.232 004926‐22‐1 35861
46 41.251 2(1H)‐Pyrimidinone, 
5‐chloro‐4,6‐diphenyl‐




9 0.641 1000351‐62‐2 71780




25 0.160 1000197‐90‐8 125534
TA B L E  3   (Continued)
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5  | CONCLUSION
Vernonia amygdalina and Solanum nigrum alkaloid extracts exhib‐
ited free radicals scavenging properties and erectogenic potential 
as typified by their arginase and phosphodiesterase‐5 enzyme in‐
hibitory activities in rats' penile tissues. These properties apparently 
provide a biochemical basis for their therapeutic efficacy and justify 
their use in folklore medicine. However, further in‐vivo and sexual 
SN
Retention 
time (min) Compound name/hit name
Quality ion (rela‐
tive intensity, %)
Percentage total of all com‐
pound (% total) CAS number








32 0.427 018030‐67‐6 196432
51 42.480 4‐Phenyl‐3,4‐dihydroisoqui‐
noline
27 0.478 006187‐58‐2 71666
52 42.693 2‐Chloro‐4,6‐di‐piperidin‐1‐
yl‐[1,3,5]triazine
25 0.224 007710‐36‐3 140588
53 43.002 Trimethylsilyl 3‐methyl‐4‐[(tri‐
methylsilyl)oxy]benzoate
23 0.212 1000378‐73‐2 155034
54 43.204 Indole‐2‐one, 2,3‐dihydro‐N‐
hydroxy‐4‐methoxy‐3,3‐di‐
methyl‐




38 1.334 1000409‐38‐7 197998
56 44.290 acetic acid, 2‐[bis(methylthio)
methylene]‐1‐phenylhy‐
drazide
43 5.278 1000401‐44‐4 114619
57 44.776 1,2‐Bis(trimethylsilyl)benzene 43 0.463 017151‐09‐6 85160
58 44.907 Cyclotrisiloxane, hexamethyl‐ 43 1.108 000541‐05‐9 85992
59 45.495 Tris(tert‐butyldimethylsily‐
loxy)arsane
43 0.284 1000366‐57‐5 260810
60 45.732 Silicic acid, diethyl 
bis(trimethylsilyl) ester
47 4.928 003555‐45‐1 154747
61 46.112 2,4,6‐Cycloheptatrien‐1‐one,	
3,5‐bis‐trimethylsilyl‐
43 0.344 1000161‐21‐8 111265
62 46.783 2′‐Hydroxypropiophenone,	
TMS	derivative
46 0.497 033342‐87‐9 85144
63 48.498 1,1,1,3,5,5,5‐
Heptamethyltrisiloxane
38 0.276 001873‐88‐7 86044
64 48.599 N‐Methyl‐1‐adamantaneacet‐
amide
38 0.786 031897‐93‐5 71587
65 49.299 1,2,4‐Benzenetricarboxylic 
acid, 4‐dodecyl dimethyl 
ester
38 0.441 033975‐29‐0 241375
66 49.922 2‐Ethylacridine 50 5.174 055751‐83‐2 71643
67 51.857 2‐Methyl‐7‐phenylindole 43 0.694 001140‐08‐5 71646
68 53.804 Methyltris(trimethylsiloxy)
silane
43 0.833 017928‐28‐8 168286
69 55.169 Benzo[h]quinoline,	
2,4‐dimethyl‐
46 1.672 000605‐67‐4 71668
70 55.264 2,4‐Cyclohexadien‐1‐one, 
3,5‐bis(1,1‐dimethylethyl)‐4‐
hydroxy‐
43 0.333 054965‐43‐4 85540
71 55.899 Carvacrol,	TMS	derivative 43 0.384 1000367‐02‐2 85400
TA B L E  3   (Continued)
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